Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening.
about
The role of melatonin in diabetes: therapeutic implicationsManipulating the circadian and sleep cycles to protect against metabolic diseaseEffects of the Internal Circadian System and Circadian Misalignment on Glucose Tolerance in Chronic Shift WorkersKeeping Up With the Clock: Circadian Disruption and Obesity RiskCircadian System and Glucose Metabolism: Implications for Physiology and DiseaseEndogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humansEffect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian PhysiologyImpact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop DiscussionsAdministration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male RatsCircadian-Based Therapies for Circadian Rhythm Sleep-Wake DisordersA single night light exposure acutely alters hormonal and metabolic responses in healthy participants.Circadian rhythms and metabolism: from the brain to the gut and back againClinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular SImpact of Common Diabetes Risk Variant in MTNR1B on Sleep, Circadian, and Melatonin Physiology.Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study.Melatonin, mitochondria, and the metabolic syndrome.Season and vitamin D status are independently associated with glucose homeostasis in pregnancy.Chronomedicine and type 2 diabetes: shining some light on melatonin.Role of sleep and circadian disruption on energy expenditure and in metabolic predisposition to human obesity and metabolic disease.Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.The role of melatonin in the onset and progression of type 3 diabetes.Short-term sleep deprivation with nocturnal light exposure alters time-dependent glucagon-like peptide-1 and insulin secretion in male volunteers.Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.Exposure to Night-Time Traffic Noise, Melatonin-Regulating Gene Variants and Change in Glycemia in Adults.Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go?The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis.Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-Analysis of Randomized Controlled Trials.Chronic Insufficient Sleep Has a Limited Impact on Circadian Rhythmicity of Subjective Hunger and Awakening Fasted Metabolic Hormones.Melatonin Uptake by Cells: An Answer to Its Relationship with Glucose?
P2860
Q26786629-C6169A17-B4C3-4CBA-AD6F-774D15388ED9Q28080813-69976A4E-7A17-4C8A-87E3-FF2ECE61A2C1Q28390267-A946879B-40B5-43D8-A8FE-B08961F851B9Q28391554-975921ED-AC9E-4F72-B767-F6559160F772Q28392828-00F075F3-DA42-4B2A-A941-B7F23F6BE9B5Q28393125-906D1537-CA39-4544-982B-116BC308B331Q28394033-EF409048-A466-4BB1-8387-BBA4FD02F67AQ28395423-A810C4F7-8903-40CE-8481-2585C1DFFF23Q28395600-750622AF-6FB6-4A22-985F-8F5680217A84Q28396494-B4FC3AE6-58F5-4AA9-8ACB-7359E8BD838FQ33656464-5797C3D8-D5BE-4AAB-A721-0B2EC75CD0A8Q33673816-B4625576-FE75-44EC-A920-F69BD0466455Q36090692-7089AE1B-7BC4-4F17-96F4-FA69FEB849D6Q36930753-077EF70F-842C-4EED-A852-B6A742F57E75Q38377376-7DBF0BAF-E2B1-4243-9CBC-FEDF5EA870C7Q38618827-98501D9C-E96F-43E8-BDC5-EB213BD722CAQ38642036-8CBCBE66-117D-4D22-9A0B-960BDCB7B6D4Q39040818-02A62E42-D8B6-42B0-9BE3-40A277AE388CQ39121535-328D16A9-C627-470E-BABA-23EBE25EDDF0Q40361963-5948241C-5565-4BCC-89BA-027638DA66E3Q41206619-B931CA16-6269-46C2-AFFD-9835FD548C3DQ42484592-5190A5FD-0D1A-4B14-A7F0-70CF89A6682CQ47096054-60754AD6-6A28-43A8-9465-6256CD618DB2Q47437450-0C81FAD4-BC31-4869-8231-9B4878119637Q47732906-964020AC-2F56-4A34-9248-FEAF8C947FF6Q53409142-5AD2ADDF-F5BE-4EC1-BA83-47DE356CFDA0Q55239758-7790E515-2011-42B9-AC72-3FD2AED66DD6Q55361470-DD315D55-5C60-44A2-95B0-C25C2B507619Q58697555-E12F1358-8CBF-4D10-8320-9DB6B711802F
P2860
Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acute melatonin administration ...... both the morning and evening.
@ast
Acute melatonin administration ...... both the morning and evening.
@en
Acute melatonin administration ...... both the morning and evening.
@nl
type
label
Acute melatonin administration ...... both the morning and evening.
@ast
Acute melatonin administration ...... both the morning and evening.
@en
Acute melatonin administration ...... both the morning and evening.
@nl
prefLabel
Acute melatonin administration ...... both the morning and evening.
@ast
Acute melatonin administration ...... both the morning and evening.
@en
Acute melatonin administration ...... both the morning and evening.
@nl
P2860
P50
P356
P1433
P1476
Acute melatonin administration ...... n both the morning and evening
@en
P2093
Patricia Rubio-Sastre
Purificación Gómez-Abellán
P2860
P304
P356
10.5665/SLEEP.4088
P577
2014-10-01T00:00:00Z